Search - tctmd.com

Displaying 21 - 40 of 389

Sort: Relevancy | Date

News Daily News

Prenatal Hyperlipidemia: ‘Canary in a Coal Mine’ for Maternal Health?

L.A. McKeown

October 17, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Daily News

Lower-Calorie Mediterranean Diet Plus Exercise Boosts Diabetes Prevention

Todd Neale

August 25, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

Gut Microbes Linked to Risk of Abdominal Aortic Aneurysms

Michael O'Riordan

August 20, 2025

News Daily News

How Much Junk Is in Junk Food? AHA Statement Aims for Clarity

L.A. McKeown

August 15, 2025

News Daily News

New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists

Yael L. Maxwell

August 14, 2025

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

News Daily News

CCTA Bests CV Risk Scores for Bolstering Lifestyle Changes, Medication Uptake

Yael L. Maxwell

June 25, 2025

News Daily News

AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty

Caitlin E. Cox

June 13, 2025

News Conference News European Congress on Obesity 2025

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

Michael O'Riordan

May 16, 2025

News Conference News European Congress on Obesity 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Caitlin E. Cox

April 23, 2025

News Daily News

AHA Tackles Need for Increased CV Prevention in Emerging Adults

Yael L. Maxwell

April 09, 2025

News Daily News

Australia’s Heat-Related Burden of CVD Holds Warnings for All

L.A. McKeown

March 20, 2025

Advertisement

Prenatal Hyperlipidemia: ‘Canary in a Coal Mine’ for Maternal Health?

ACC: It’s Time for Clinicians to Address Inflammation in CVD

September 2025 Dispatch for the CV Team

CVD Still the Leading Cause of Death and Disease Globally

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Lower-Calorie Mediterranean Diet Plus Exercise Boosts Diabetes Prevention

August 2025 Dispatch for the CV Team

Gut Microbes Linked to Risk of Abdominal Aortic Aneurysms

How Much Junk Is in Junk Food? AHA Statement Aims for Clarity

New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

CCTA Bests CV Risk Scores for Bolstering Lifestyle Changes, Medication Uptake

AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

AHA Tackles Need for Increased CV Prevention in Emerging Adults

Australia’s Heat-Related Burden of CVD Holds Warnings for All

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content